Digital Look

GW Pharmaceuticals (GWP)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE AIM 50

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

80.25p

Change Today:

1.00p
52 Week High: 130.00p
52 Week Low: 78.50p

Currency: UK Pounds
Shares Issued: 133.32m
Volume: 70,999

Market Cap: £106.99m
RiskGrade: 538
Beta: 0.34

Update - Nomura has downgraded GW Pharmaceuticals - find more downgrades with the Broker Views gadget Find out more

GWP Overview

GW Pharmaceuticals is in the pharmaceuticals & biotechnology sector and is currently trading at 80.25p per share. In the last year GW Pharmaceuticals's share price has ranged from 78.50p to 130.00p and brokers are currently rating this stock as 'buy'.

1 Day Chart

6 Month Chart

More GW Pharmaceuticals charts

Financials

	Latest	F'cast
Div Yield	0.0%	0.0%
Div Cover	n/a	n/a
Op Mrgn	7.7%	5.1%
ROCE	18.2%

	Latest	F'cast
P/E	38.2	36.4
PEG	n/a	10.2
Pr/Revenue	3.6	3.2
Pr/Book	6.1

	Latest	F'cast
Revenue	-3.4%	11.8%
PBT	-45.1%	-32.7%
EPS	-41.7%	3.6%
DPS	n/a	n/a

GWP Fundamentals

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
30-Sep-07	5.68	(12.60)	(8.80)p	n/a	n/a	n/a	n/a	0.0%
30-Sep-08	11.77	(10.19)	(6.80)p	n/a	n/a	n/a	n/a	0.0%
30-Sep-09	24.12	1.15	1.20p	72.9	n/a	n/a	n/a	0.0%
30-Sep-10	30.68	4.60	3.60p	27.8	0.1	+200%	n/a	0.0%
30-Sep-11	29.63	2.53	2.10p	46.7	n/a	-42%	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GWP Forecasts

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
30-Sep-12	33.13	1.70	2.17p	36.9	10.3	+4%	n/a	0.0%
30-Sep-13	31.97	(1.17)	(0.39)p	n/a	n/a	+n/a	n/a	0.0%

GW Pharmaceuticals forecasts

GWP Company Announcements

Director/PDMR Shareholding	23-May-2012	15:56	RNS
Third Cancer Pain Trial Commences	22-May-2012	07:00	RNS
Interim Results	22-May-2012	07:00	RNS

More GW Pharmaceuticals gwp company announcements

GWP ShareCast News

Journal of Pain review boost for GW Pharm	23-Apr-2012	ShareCast
Ophir Energy director makes massive sale	02-Apr-2012	ShareCast
UPDATE: Tuesday broker round-up	25-Oct-2011	ShareCast

More GW Pharmaceuticals ShareCast news

GWP Top Newspaper Links

Novartis drug deal is just the tonic for GW Phar...	12-Apr-2011	Daily Mail
GW SIGNS £20M SATIVEX DEAL WITH NOVARTIS	12-Apr-2011	Express & Star
GW signs Sativex cannabis-based drug deal with N...	12-Apr-2011	Telegraph

Latest GWP Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

GWP Market Data

Currency	UK Pounds
Share Price	80.25p
Change Today	1.00p
% Change	1.26 %
52 Week High	130.00p
52 Week Low	78.50p
Volume	70,999
Shares Issued	133.32m
Market Cap	£106.99m
Beta	0.34
RiskGrade	538